Paper33567448
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.
Wang Z and 33 others. Nature, 2021. Cited by 1,161 papers, by iCite.
Cite this record
ConductScience Library. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Papers, record 33567448. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33567448
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics27
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Viral | Major topic |
| COVID-19 | Major topic |
| COVID-19 Vaccines | Major topic |
| SARS-CoV-2 | Major topic |
| Spike Glycoprotein, Coronavirus | Major topic |
| Vaccines, Synthetic | Major topic |
| 2019-nCoV Vaccine mRNA-1273 | |
| Adult | |
| Aged | |
| Antibodies, Monoclonal | |
| Antibodies, Neutralizing | |
| B-Lymphocytes | |
| BNT162 Vaccine | |
| Cryoelectron Microscopy | |
| Epitopes, B-Lymphocyte | |
| Female | |
| Humans | |
| Immunization, Secondary | |
| Immunoglobulin G | |
| Immunoglobulin M | |
| Immunologic Memory | |
| Male | |
| Middle Aged | |
| Models, Molecular | |
| Mutation | |
| Neutralization Tests | |
| mRNA Vaccines |
Source PubMed
Grants11
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P50 AI150464-13 | NIH HHS | United States | P50AI150464 | PubMed and NIH | NIH RePORTER |
| Wellcome Trust | United Kingdom | PubMed | PubMed | ||
| P01 AI138938 | NIAID NIH HHS | United States | P01AI138938 | PubMed and NIH | NIH RePORTER |
| R01 AI78788 | NIH HHS | United States | R01AI078788 | PubMed and NIH | NIH RePORTER |
| P01 AI138398-S1 | NIH HHS | United States | P01AI138398 | PubMed | NIH RePORTER |
| Howard Hughes Medical Institute | United States | PubMed | PubMed | ||
| 2U19AI111825 | NIH HHS | United States | U19AI111825 | PubMed and NIH | NIH RePORTER |
| R37AI064003 | NIH | NIH RePORTER | |||
| UL1TR001866 | NIH | NIH RePORTER | |||
| ZIAAR041184 | NIH | NIH RePORTER | |||
| ZIAAR041211 | NIH | NIH RePORTER |
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Update of | 33501451 | PubMed | ||
| Comment in | 34023862 | SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern. | https://conductscience.org/library/papers/34023862 | PubMed |
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32425270 | Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells. | Cell | 2020 | https://conductscience.org/library/papers/32425270 | PubMed |
| 2 | 33831132 | A human coronavirus evolves antigenically to escape antibody immunity. | PLoS Pathog | 2021 | https://conductscience.org/library/papers/33831132 | PubMed |
| 3 | 32698192 | Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. | Nature | 2020 | https://conductscience.org/library/papers/32698192 | PubMed |
| 4 | 30377346 | A fully automatic method yielding initial models from high-resolution cryo-electron microscopy maps. | Nat Methods | 2018 | https://conductscience.org/library/papers/30377346 | PubMed |
| 5 | 33592168 | Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. | Cell Host Microbe | 2021 | https://conductscience.org/library/papers/33592168 | PubMed |
| 6 | 33558724 | Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera. | Nat Med | 2021 | https://conductscience.org/library/papers/33558724 | PubMed |
| 7 | 33649194 | Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil. | J Virol | 2021 | https://conductscience.org/library/papers/33649194 | PubMed |
| 8 | 33332778 | REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33332778 | PubMed |
| 9 | 32540902 | Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. | Science | 2020 | https://conductscience.org/library/papers/32540902 | PubMed |
| 10 | 33404586 | Genetic Variants of SARS-CoV-2-What Do They Mean? | JAMA | 2021 | https://conductscience.org/library/papers/33404586 | PubMed |
| 11 | 33270381 | Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33270381 | PubMed |
| 12 | 32805734 | Structures and distributions of SARS-CoV-2 spike proteins on intact virions. | Nature | 2020 | https://conductscience.org/library/papers/32805734 | PubMed |
| 13 | 32555388 | Convergent antibody responses to SARS-CoV-2 in convalescent individuals. | Nature | 2020 | https://conductscience.org/library/papers/32555388 | PubMed |
| 14 | 33112236 | Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. | Elife | 2020 | https://conductscience.org/library/papers/33112236 | PubMed |
| 15 | 33495308 | Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. | Science | 2021 | https://conductscience.org/library/papers/33495308 | PubMed |
| 16 | 23226220 | Onset of immune senescence defined by unbiased pyrosequencing of human immunoglobulin mRNA repertoires. | PLoS One | 2012 | https://conductscience.org/library/papers/23226220 | PubMed |
| 17 | 32722908 | Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32722908 | PubMed |
| 18 | 32692348 | Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. | J Exp Med | 2020 | https://conductscience.org/library/papers/32692348 | PubMed |
| 19 | 33780970 | Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma. | Nature | 2021 | https://conductscience.org/library/papers/33780970 | PubMed |
| 20 | 32422645 | Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. | Nature | 2020 | https://conductscience.org/library/papers/32422645 | PubMed |
Cited by917
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,161 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42903912 | A human monoclonal antibody neutralizes SARS-CoV-2 Omicron variants by targeting the upstream region of spike protein HR2 motif. | Hlife | 2024 | https://conductscience.org/library/papers/42903912 | PubMed |
| 42888436 | The advances and challenges of mRNA-LNP application in fields of hematology and oncology therapeutics. | J Hematol Oncol | 2026 | https://conductscience.org/library/papers/42888436 | PubMed |
| 42743315 | R1-32-like public antibodies acquire tolerance to SARS-CoV-2 antigenic drift through somatic hypermutation. | PLoS Biol | 2026 | https://conductscience.org/library/papers/42743315 | PubMed |
| 42497177 | Broad and durable protection against SARS-CoV-2 and SARS-CoV by an intranasal chimpanzee adenovirus vaccine expressing tandem RBDs and nucleocapsid. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/42497177 | PubMed |
| 42479777 | Environmental drivers of low vaccine responsiveness in a lab-to-wild rodent model. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/42479777 | PubMed |
| 42282689 | A designed overlapping variant immunogen pool elicits broad sarbecovirus neutralization. | bioRxiv | 2026 | https://conductscience.org/library/papers/42282689 | PubMed |
| 42189851 | Utilizing virus genomic surveillance to predict vaccine effectiveness. | PLoS Comput Biol | 2026 | https://conductscience.org/library/papers/42189851 | PubMed |
| 42100635 | High-sensitivity electrochemical immunosensor for anti-SARS-CoV-2 IgG detection using screen-printed carbon/cerium oxide-gold electrode. | ADMET DMPK | 2026 | https://conductscience.org/library/papers/42100635 | PubMed |
| 42015414 | Antibody-antigen neutralization prediction by integrating structural information distillation and physicochemical constraints. | Brief Bioinform | 2026 | https://conductscience.org/library/papers/42015414 | PubMed |
| 42014747 | Impact of timely vaccination and genomic surveillance on controlling consecutive waves of SARS-CoV-2 variants. | Sci Rep | 2026 | https://conductscience.org/library/papers/42014747 | PubMed |
| 42009999 | Safety and efficacy of COVID-19 vaccines in pregnant and lactating women: a comprehensive review. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42009999 | PubMed |
| 41987210 | Mechanisms underlying immunodynamics of layered defenses elicited by mRNA vaccination in children. | BMC Med | 2026 | https://conductscience.org/library/papers/41987210 | PubMed |
| 41985440 | Immunological memory to vaccines. | Immunity | 2026 | https://conductscience.org/library/papers/41985440 | PubMed |
| 41983390 | Peripheral vaccination-induced brain-resident memory CD8+ T cells durably protect mice against intracranial malignancy. | J Clin Invest | 2026 | https://conductscience.org/library/papers/41983390 | PubMed |
| 41927882 | AI-aided engineering and production optimization of chimeric hetero-viral capping enzymes for mRNA vaccines. | Sci Rep | 2026 | https://conductscience.org/library/papers/41927882 | PubMed |
| 41912532 | Self-amplifying COVID-19 mRNA vaccination induces longitudinally enhanced antibody function in a Phase 3 trial. | NPJ Vaccines | 2026 | https://conductscience.org/library/papers/41912532 | PubMed |
| 41882251 | Design and immunogenicity evaluation of pan-recombinant vaccines based on the consensus sequence of severe acute respiratory syndrome coronavirus-2 spike protein. | Sci Rep | 2026 | https://conductscience.org/library/papers/41882251 | PubMed |
| 41813804 | DNA origami vaccine nanoparticles improve humoral and cellular immune responses to infectious diseases. | Nat Biomed Eng | 2026 | https://conductscience.org/library/papers/41813804 | PubMed |
| 41746934 | Designing a novel vaccine against COVID-19 based on spike SARS-Cov-2 notable mutations using immunoinformatics approaches. | PLoS One | 2026 | https://conductscience.org/library/papers/41746934 | PubMed |
| 41712614 | Immune-focused RBD nanoparticles induce cross-reactive, RBS-directed responses capable of variant-resistant SARS-CoV-2 neutralization. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/41712614 | PubMed |
Genes18
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33567448
GET https://conductscience.org/api/papers/v1/33567448/authors?page=2